News

Collagen Solutions has been acquired by RTI Surgical

October 2024 – England & Company is pleased to announce that it served as the exclusive financial advisor to Collagen Solutions, a premier global supplier, developer, and manufacturer of engineered biomaterial-based medical devices and components with applications in regenerative medicine, in its sale to RTI Surgical, a leading contract development and manufacturing organization (“CDMO”) in tissue engineering for regenerative medicine. RTI is a portfolio company of Montagu Private Equity, a leading Europe and U.S.-based private equity firm with $12 billion of assets under management.

“The England & Company team are experts in medical device marketing and contract manufacturing, with extensive relationships in the biomaterials and regenerative medicine spaces. They found us the ideal partner for this business and negotiated strong terms for us,” said Rick Mulford, CEO of Collagen Solutions.

Collagen Solutions provides its OEM customers with high-quality components and fully assembled devices made from medical-grade collagen and xenograft tissue. These devices are used in various therapeutic areas, including cardiovascular, wound care, orthopedics and sports medicine, dental, biosurgery, and neurosurgery. The Company is based in Eden Prairie, MN, and has additional strategically located manufacturing sites in the U.K., New Zealand, and Glencoe, MN.